The Paula Takacs Foundation for Sarcoma Research is immensely proud to announce the establishment of the Paula Takacs Foundation Endowed Chair of Sarcoma Research at…
Read More
PAULA TAKACS FOUNDATION PRESENTS ITS LARGEST ANNUAL RESEARCH GRANT EVER On January 10, 2024, the Paula Takacs Foundation held its 2023 Grant Presentation, celebrating its…
Read More
On December 9, 2022, the Food and Drug Administration (FDA) approved atezolizumab (Tecentriq, Genentech, Inc.) for adult and pediatric patients 2 years of age and…
Read More
Dana-Farber Cancer Institute announced that The Rossy Foundation has committed $10 million to establish the David Liposarcoma Research Initiative. The five-year initiative will spearhead groundbreaking research…
Read More
Family cancer clusters are frightening and not well-studied. Frankly, it takes courage (and dollars to cover expenses not often covered by insurance) to delve into…
Read More